Berlin, Germany

Aileen Höhne

This inventor holds 2 USPTO granted patents and 5 published patent applications and 1 EPO patent. Top assignee: 3B Pharmaceuticals Gmbh. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Aileen Höhne. Retrieved from https://idiyas.com/inventor/aileen-höhne

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 50.0

 

Average Co-Inventor Count = 10.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Aileen Höhne: Innovator in Pharmaceutical Compounds

Introduction

Aileen Höhne is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds. Her work focuses on enhancing therapeutic options through novel chemical formulations.

Latest Patents

Aileen Höhne holds a patent for her invention titled "Compounds comprising a fibroblast activation protein ligand and use thereof." This patent involves a compound that includes a cyclic peptide and a chelator, along with its various applications in medical treatments. She has successfully secured 1 patent for her groundbreaking work.

Career Highlights

Aileen is currently employed at 3B Pharmaceuticals GmbH, where she continues to advance her research and development efforts. Her role at the company allows her to collaborate with other experts in the field and contribute to innovative pharmaceutical solutions.

Collaborations

Aileen has worked alongside notable colleagues such as Frank Osterkamp and Dirk Zboralski. Their combined expertise fosters a collaborative environment that enhances the potential for groundbreaking discoveries in the pharmaceutical industry.

Conclusion

Aileen Höhne's contributions to the field of pharmaceuticals exemplify her dedication to innovation and research. Her patent and ongoing work at 3B Pharmaceuticals GmbH highlight her role as a key player in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…